[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global RNA-Based Therapeutics Market Research Report 2021-2025

April 2021 | 143 pages | ID: GBA8E3375C63EN
9Dimen Research

US$ 3,200.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
Thanks to its ability to render targeted solutions for chronic diseases such as cancer, AIDS, rare genetic disorders, and certain cardiovascular conditions, RNA based therapeutics is expected to significantly impact the global pharmaceutical industry, according to research, the global RNA-Based Therapeutics market is projected to reach USD 992 million by 2020.

Base on type, the oncology segment is emerging as the leading target indication which accounts for 32% of market share, and RNA interference (RNAi) and RNA antisense technologies appear to be dominating the market. RNAi is a gene silencing technology in which RNA molecules inhibit gene expression by targeting and destroying specific mRNA molecules.

Geographically, the North America is dominating the market across the world, which is expected to grow at highest CAGR of 20.9% for the forecast period, due to the government of United States, through its National Institute of Health (NIH), provides funds for RNA therapeutics research, thus assist in propelling the growth of this market. To boost the research activities the U.S. FDA is providing fast track designation to the RNA products, which are in the pipeline.

Region followed by Europe, Europe is experiencing a significant growth for next five years, due to their well established medical insurance, the RNA-Based Therapeutics have a wide adoption by patience; the Asia Pacific is considered as most promising market as their largest population and positive economy, according the report, the Asia Pacific is expected be the largest market globally by 2030.

The global leading companies in this market are Alnylam Pharmaceuticals, Inc., Benitec Biopharma Limited, Cenix BioScience GmbH, Dicerna Pharmaceuticals Inc., Genzyme Corporation, ISIS pharmaceuticals Inc., Quark Pharmaceuticals, Inc., Silence Therapeutics PLC, and Tekmira Pharmaceuticals Corp.
PART I RNA-BASED THERAPEUTICS INDUSTRY OVERVIEW

CHAPTER ONE RNA-BASED THERAPEUTICS INDUSTRY OVERVIEW

1.1 RNA-Based Therapeutics Definition
1.2 RNA-Based Therapeutics Classification Analysis
  1.2.1 RNA-Based Therapeutics Main Classification Analysis
  1.2.2 RNA-Based Therapeutics Main Classification Share Analysis
1.3 RNA-Based Therapeutics Application Analysis
  1.3.1 RNA-Based Therapeutics Main Application Analysis
  1.3.2 RNA-Based Therapeutics Main Application Share Analysis
1.4 RNA-Based Therapeutics Industry Chain Structure Analysis
1.5 RNA-Based Therapeutics Industry Development Overview
  1.5.1 RNA-Based Therapeutics Product History Development Overview
  1.5.1 RNA-Based Therapeutics Product Market Development Overview
1.6 RNA-Based Therapeutics Global Market Comparison Analysis
  1.6.1 RNA-Based Therapeutics Global Import Market Analysis
  1.6.2 RNA-Based Therapeutics Global Export Market Analysis
  1.6.3 RNA-Based Therapeutics Global Main Region Market Analysis
  1.6.4 RNA-Based Therapeutics Global Market Comparison Analysis
  1.6.5 RNA-Based Therapeutics Global Market Development Trend Analysis

CHAPTER TWO RNA-BASED THERAPEUTICS UP AND DOWN STREAM INDUSTRY ANALYSIS

2.1 Upstream Raw Materials Analysis
  2.1.1 Proportion of Manufacturing Cost
  2.1.2 Manufacturing Cost Structure of RNA-Based Therapeutics Analysis
2.2 Down Stream Market Analysis
  2.2.1 Down Stream Market Analysis
  2.2.2 Down Stream Demand Analysis
  2.2.3 Down Stream Market Trend Analysis

PART II ASIA RNA-BASED THERAPEUTICS INDUSTRY (THE REPORT COMPANY INCLUDING THE BELOW LISTED BUT NOT ALL)

CHAPTER THREE ASIA RNA-BASED THERAPEUTICS MARKET ANALYSIS

3.1 Asia RNA-Based Therapeutics Product Development History
3.2 Asia RNA-Based Therapeutics Competitive Landscape Analysis
3.3 Asia RNA-Based Therapeutics Market Development Trend

CHAPTER FOUR 2016-2021 ASIA RNA-BASED THERAPEUTICS PRODUCTIONS SUPPLY SALES DEMAND MARKET STATUS AND FORECAST

4.1 2016-2021 RNA-Based Therapeutics Production Overview
4.2 2016-2021 RNA-Based Therapeutics Production Market Share Analysis
4.3 2016-2021 RNA-Based Therapeutics Demand Overview
4.4 2016-2021 RNA-Based Therapeutics Supply Demand and Shortage
4.5 2016-2021 RNA-Based Therapeutics Import Export Consumption
4.6 2016-2021 RNA-Based Therapeutics Cost Price Production Value Gross Margin

CHAPTER FIVE ASIA RNA-BASED THERAPEUTICS KEY MANUFACTURERS ANALYSIS

5.1 Company A
  5.1.1 Company Profile
  5.1.2 Product Picture and Specification
  5.1.3 Product Application Analysis
  5.1.4 Capacity Production Price Cost Production Value
  5.1.5 Contact Information
5.2 Company B
  5.2.1 Company Profile
  5.2.2 Product Picture and Specification
  5.2.3 Product Application Analysis
  5.2.4 Capacity Production Price Cost Production Value
  5.2.5 Contact Information
5.3 Company C
  5.3.1 Company Profile
  5.3.2 Product Picture and Specification
  5.3.3 Product Application Analysis
  5.3.4 Capacity Production Price Cost Production Value
  5.3.5 Contact Information
5.4 Company D
  5.4.1 Company Profile
  5.4.2 Product Picture and Specification
  5.4.3 Product Application Analysis
  5.4.4 Capacity Production Price Cost Production Value
  5.4.5 Contact Information

CHAPTER SIX ASIA RNA-BASED THERAPEUTICS INDUSTRY DEVELOPMENT TREND

6.1 2021-2025 RNA-Based Therapeutics Production Overview
6.2 2021-2025 RNA-Based Therapeutics Production Market Share Analysis
6.3 2021-2025 RNA-Based Therapeutics Demand Overview
6.4 2021-2025 RNA-Based Therapeutics Supply Demand and Shortage
6.5 2021-2025 RNA-Based Therapeutics Import Export Consumption
6.6 2021-2025 RNA-Based Therapeutics Cost Price Production Value Gross Margin

PART III NORTH AMERICAN RNA-BASED THERAPEUTICS INDUSTRY (THE REPORT COMPANY INCLUDING THE BELOW LISTED BUT NOT ALL)

CHAPTER SEVEN NORTH AMERICAN RNA-BASED THERAPEUTICS MARKET ANALYSIS

7.1 North American RNA-Based Therapeutics Product Development History
7.2 North American RNA-Based Therapeutics Competitive Landscape Analysis
7.3 North American RNA-Based Therapeutics Market Development Trend

CHAPTER EIGHT 2016-2021 NORTH AMERICAN RNA-BASED THERAPEUTICS PRODUCTIONS SUPPLY SALES DEMAND MARKET STATUS AND FORECAST

8.1 2016-2021 RNA-Based Therapeutics Production Overview
8.2 2016-2021 RNA-Based Therapeutics Production Market Share Analysis
8.3 2016-2021 RNA-Based Therapeutics Demand Overview
8.4 2016-2021 RNA-Based Therapeutics Supply Demand and Shortage
8.5 2016-2021 RNA-Based Therapeutics Import Export Consumption
8.6 2016-2021 RNA-Based Therapeutics Cost Price Production Value Gross Margin

CHAPTER NINE NORTH AMERICAN RNA-BASED THERAPEUTICS KEY MANUFACTURERS ANALYSIS

9.1 Company A
  9.1.1 Company Profile
  9.1.2 Product Picture and Specification
  9.1.3 Product Application Analysis
  9.1.4 Capacity Production Price Cost Production Value
  9.1.5 Contact Information
9.2 Company B
  9.2.1 Company Profile
  9.2.2 Product Picture and Specification
  9.2.3 Product Application Analysis
  9.2.4 Capacity Production Price Cost Production Value
  9.2.5 Contact Information

CHAPTER TEN NORTH AMERICAN RNA-BASED THERAPEUTICS INDUSTRY DEVELOPMENT TREND

10.1 2021-2025 RNA-Based Therapeutics Production Overview
10.2 2021-2025 RNA-Based Therapeutics Production Market Share Analysis
10.3 2021-2025 RNA-Based Therapeutics Demand Overview
10.4 2021-2025 RNA-Based Therapeutics Supply Demand and Shortage
10.5 2021-2025 RNA-Based Therapeutics Import Export Consumption
10.6 2021-2025 RNA-Based Therapeutics Cost Price Production Value Gross Margin

PART IV EUROPE RNA-BASED THERAPEUTICS INDUSTRY ANALYSIS (THE REPORT COMPANY INCLUDING THE BELOW LISTED BUT NOT ALL)

CHAPTER ELEVEN EUROPE RNA-BASED THERAPEUTICS MARKET ANALYSIS

11.1 Europe RNA-Based Therapeutics Product Development History
11.2 Europe RNA-Based Therapeutics Competitive Landscape Analysis
11.3 Europe RNA-Based Therapeutics Market Development Trend

CHAPTER TWELVE 2016-2021 EUROPE RNA-BASED THERAPEUTICS PRODUCTIONS SUPPLY SALES DEMAND MARKET STATUS AND FORECAST

12.1 2016-2021 RNA-Based Therapeutics Production Overview
12.2 2016-2021 RNA-Based Therapeutics Production Market Share Analysis
12.3 2016-2021 RNA-Based Therapeutics Demand Overview
12.4 2016-2021 RNA-Based Therapeutics Supply Demand and Shortage
12.5 2016-2021 RNA-Based Therapeutics Import Export Consumption
12.6 2016-2021 RNA-Based Therapeutics Cost Price Production Value Gross Margin

CHAPTER THIRTEEN EUROPE RNA-BASED THERAPEUTICS KEY MANUFACTURERS ANALYSIS

13.1 Company A
  13.1.1 Company Profile
  13.1.2 Product Picture and Specification
  13.1.3 Product Application Analysis
  13.1.4 Capacity Production Price Cost Production Value
  13.1.5 Contact Information
13.2 Company B
  13.2.1 Company Profile
  13.2.2 Product Picture and Specification
  13.2.3 Product Application Analysis
  13.2.4 Capacity Production Price Cost Production Value
  13.2.5 Contact Information

CHAPTER FOURTEEN EUROPE RNA-BASED THERAPEUTICS INDUSTRY DEVELOPMENT TREND

14.1 2021-2025 RNA-Based Therapeutics Production Overview
14.2 2021-2025 RNA-Based Therapeutics Production Market Share Analysis
14.3 2021-2025 RNA-Based Therapeutics Demand Overview
14.4 2021-2025 RNA-Based Therapeutics Supply Demand and Shortage
14.5 2021-2025 RNA-Based Therapeutics Import Export Consumption
14.6 2021-2025 RNA-Based Therapeutics Cost Price Production Value Gross Margin

PART V RNA-BASED THERAPEUTICS MARKETING CHANNELS AND INVESTMENT FEASIBILITY

CHAPTER FIFTEEN RNA-BASED THERAPEUTICS MARKETING CHANNELS DEVELOPMENT PROPOSALS ANALYSIS

15.1 RNA-Based Therapeutics Marketing Channels Status
15.2 RNA-Based Therapeutics Marketing Channels Characteristic
15.3 RNA-Based Therapeutics Marketing Channels Development Trend
15.2 New Firms Enter Market Strategy
15.3 New Project Investment Proposals

CHAPTER SIXTEEN DEVELOPMENT ENVIRONMENTAL ANALYSIS

16.1 China Macroeconomic Environment Analysis
16.2 European Economic Environmental Analysis
16.3 United States Economic Environmental Analysis
16.4 Japan Economic Environmental Analysis
16.5 Global Economic Environmental Analysis

CHAPTER SEVENTEEN RNA-BASED THERAPEUTICS NEW PROJECT INVESTMENT FEASIBILITY ANALYSIS

17.1 RNA-Based Therapeutics Market Analysis
17.2 RNA-Based Therapeutics Project SWOT Analysis
17.3 RNA-Based Therapeutics New Project Investment Feasibility Analysis

PART VI GLOBAL RNA-BASED THERAPEUTICS INDUSTRY CONCLUSIONS

CHAPTER EIGHTEEN 2016-2021 GLOBAL RNA-BASED THERAPEUTICS PRODUCTIONS SUPPLY SALES DEMAND MARKET STATUS AND FORECAST

18.1 2016-2021 RNA-Based Therapeutics Production Overview
18.2 2016-2021 RNA-Based Therapeutics Production Market Share Analysis
18.3 2016-2021 RNA-Based Therapeutics Demand Overview
18.4 2016-2021 RNA-Based Therapeutics Supply Demand and Shortage
18.5 2016-2021 RNA-Based Therapeutics Import Export Consumption
18.6 2016-2021 RNA-Based Therapeutics Cost Price Production Value Gross Margin

CHAPTER NINETEEN GLOBAL RNA-BASED THERAPEUTICS INDUSTRY DEVELOPMENT TREND

19.1 2021-2025 RNA-Based Therapeutics Production Overview
19.2 2021-2025 RNA-Based Therapeutics Production Market Share Analysis
19.3 2021-2025 RNA-Based Therapeutics Demand Overview
19.4 2021-2025 RNA-Based Therapeutics Supply Demand and Shortage
19.5 2021-2025 RNA-Based Therapeutics Import Export Consumption
19.6 2021-2025 RNA-Based Therapeutics Cost Price Production Value Gross Margin

CHAPTER TWENTY GLOBAL RNA-BASED THERAPEUTICS INDUSTRY RESEARCH CONCLUSIONS


More Publications